Literature DB >> 18709661

Astrocytes are very sensitive to develop innate immune responses to lipid-carried short interfering RNA.

Roser Gorina1, Tomàs Santalucia, Valérie Petegnief, Aroa Ejarque-Ortiz, Josep Saura, Anna M Planas.   

Abstract

Short interfering RNA (siRNA) inhibits the synthesis of specific proteins through RNA interference (RNAi). However, siRNA can induce innate immune responses that are mediated by toll-like receptors (TLRs) in cells of the immune system. Here, we sought to evaluate whether siRNA can induce such responses in glial cells. We examined the effects of various siRNA sequences prepared with lipids (oligofectamine). Lipid-siRNA induced variable degrees of silencing-independent nonspecific effects, e.g. increased Stat1 and Cox-2 expression and release of IL-6 and IP-10 in primary astroglia. This was prevented through chemical modification of siRNA by nucleoside 2'-O-methylation, without impairing specific gene silencing. Lipid-siRNA also induced nonspecific responses in purified astroglia, but not in microglia, or 3T3 cells. The highest TLR7 and TLR3 mRNA expression was found in microglia and purified astroglia, respectively. Accordingly, the TLR3 agonist poly(I:C) (PIC) induced higher release of IFN-beta in primary and purified astroglia than in microglia. As siRNA, PIC induced IP-10, Stat1, VCAM-1, and Cox-2 and increased TLR3 mRNA expression. The effects of lipid-siRNA in purified astrocytes were attenuated after silencing TLR3 or TLR7 expression, and by the PKR inhibitor 2-aminopurine. Furthermore, lipid-siRNA induced the expression of RIG-I. In contrast, siRNA devoid of lipids did not enter the astrocytes, did not silence gene expression, and did not induce Stat1 or Cox-2. The results show that, in astroglia, lipid-siRNA induces innate immune responses that are mediated, at least in part, by intracellular mechanism dependent on TLR7, TLR3, and helicases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18709661     DOI: 10.1002/glia.20738

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  21 in total

Review 1.  Innate immunity in the central nervous system.

Authors:  Richard M Ransohoff; Melissa A Brown
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

2.  Short small-interfering RNAs produce interferon-α-mediated analgesia.

Authors:  P H Tan; Y J Gao; T Berta; Z Z Xu; R R Ji
Journal:  Br J Anaesth       Date:  2012-02-03       Impact factor: 9.166

3.  Modulation of inflammatory cytokines and mitogen-activated protein kinases by acetate in primary astrocytes.

Authors:  Mahmoud L Soliman; Colin K Combs; Thad A Rosenberger
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-12       Impact factor: 4.147

4.  Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes.

Authors:  Miriam Font-Nieves; M Glòria Sans-Fons; Roser Gorina; Ester Bonfill-Teixidor; Angélica Salas-Pérdomo; Leonardo Márquez-Kisinousky; Tomàs Santalucia; Anna M Planas
Journal:  J Biol Chem       Date:  2012-01-04       Impact factor: 5.157

5.  ATP-mediated Erk1/2 activation stimulates bacterial capture by filopodia, which precedes Shigella invasion of epithelial cells.

Authors:  Stéphane Romero; Gianfranco Grompone; Nathalie Carayol; Joëlle Mounier; Stéphanie Guadagnini; Marie-Christine Prevost; Philippe J Sansonetti; Guy Tran Van Nhieu
Journal:  Cell Host Microbe       Date:  2011-06-16       Impact factor: 21.023

Review 6.  Novel HIV-1 therapeutics through targeting altered host cell pathways.

Authors:  William Coley; Kylene Kehn-Hall; Rachel Van Duyne; Fatah Kashanchi
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

Review 7.  Sequence-non-specific effects of RNA interference triggers and microRNA regulators.

Authors:  Marta Olejniczak; Paulina Galka; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2009-10-20       Impact factor: 16.971

Review 8.  The complex role of neuroinflammation in glaucoma.

Authors:  Ileana Soto; Gareth R Howell
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-03       Impact factor: 6.915

9.  Dexmedetomidine inhibits tumor necrosis factor-alpha and interleukin 6 in lipopolysaccharide-stimulated astrocytes by suppression of c-Jun N-terminal kinases.

Authors:  Xiaobao Zhang; Jun Wang; Wenyi Qian; Jingjing Zhao; Li Sun; Yanning Qian; Hang Xiao
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

10.  The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury.

Authors:  Gaby Enzmann; Caroline Mysiorek; Roser Gorina; Yu-Jung Cheng; Sharang Ghavampour; Melanie-Jane Hannocks; Vincent Prinz; Ulrich Dirnagl; Matthias Endres; Marco Prinz; Rudi Beschorner; Patrick N Harter; Michel Mittelbronn; Britta Engelhardt; Lydia Sorokin
Journal:  Acta Neuropathol       Date:  2012-12-27       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.